Related Experiment Video
Updated: Jul 4, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Micrococcus Peritonitis Complicating Peritoneal Dialysis
1The Warren Alpert Medical School of Brown University, Providence, RI.
Abstract:
Peritonitis, a serious complication of peritoneal dialysis (PD), can be caused by opportunistic pathogens like Micrococcus species on rare occasions. We present a case of Micrococcus sp peritonitis in a 55-year-old female with end-stage kidney disease on continuous cycling peritoneal dialysis for one year who presented with cloudy effluent. Initial treatment against Micrococcus sp with vancomycin, gentamicin, and prophylactic oral nystatin was successful. However, one month later, the patient presented with abdominal pain and dialysate culture again grew Micrococcus sp. Treatment with vancomycin was unsuccessful in resolving culture positivity. The patient was transitioned to hemodialysis for non-medical reasons and then was later restarted on PD without further peritonitis episodes. Micrococcus sp peritonitis in PD poses treatment challenges due to limited guidelines. Intraperitoneal vancomycin is commonly used to target Micrococcus isolates although there is a high incidence of treatment failure. This case report highlights the need for continued reporting to enhance identification, prevention, and patient outcomes in Micrococcus sp peritonitis during PD.
Insights
Micrococcus species peritonitis in peritoneal dialysis (PD) patients presents treatment challenges. This case highlights treatment failure with vancomycin and the need for better prevention and patient outcomes.
Area of Science:
- Nephrology
- Infectious Diseases
Background:
- Peritonitis is a serious complication of peritoneal dialysis (PD).
- Micrococcus species are rare opportunistic pathogens causing PD peritonitis.
Observation:
- A 55-year-old female on PD developed recurrent Micrococcus sp peritonitis.
- Initial vancomycin treatment failed to resolve the second episode of peritonitis.
Findings:
- Micrococcus sp peritonitis in PD poses significant treatment challenges.
- Intraperitoneal vancomycin shows a high incidence of treatment failure against Micrococcus isolates.
Implications:
- This case underscores the need for enhanced identification and prevention strategies for Micrococcus sp peritonitis in PD patients.
- Further case reporting is crucial for improving patient outcomes and developing effective treatment guidelines.

